Achondrogenesis type II: genes and variants
Explore variant evidence for Achondrogenesis type II across 2 analyzed proteins (COL2A1, SLC26A2). Linked ClinVar records include 48 pathogenic or likely pathogenic variants, 131 variants of uncertain significance and 30 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Achondrogenesis type II
COL2A1: Collagen alpha-1(II) chain
It provides the principal fibrillar collagen framework of cartilage and is also important in the vitreous and inner ear. Pathogenic variants cause a broad type II collagenopathy spectrum including Stickler syndrome, spondyloepiphyseal dysplasia, and severe skeletal dysplasias.
34 ClinVar pathogenic / likely pathogenic and 13 uncertain variants in COL2A1 have source records linked to Achondrogenesis type II. Association strength is not clinical gene validity.
SLC26A2: Sulfate transporter
A sulfate transporter that supplies chondrocytes with sulfate for cartilage proteoglycan production. Variants cause a spectrum of skeletal disorders, including diastrophic dysplasia.
14 ClinVar pathogenic / likely pathogenic and 148 uncertain variants in SLC26A2 have source records linked to Achondrogenesis type II. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Achondrogenesis type II
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| COL2A1 G546S | 546 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| SLC26A2 A386V | 386 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC26A2 Q454P | 454 | Pathogenic / likely pathogenic (★★) | |
| COL2A1 G423S | 423 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL2A1 G504S | 504 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL2A1 G732S | 732 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL2A1 G801S | 801 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL2A1 G1008V | 1008 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL2A1 G1029C | 1029 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL2A1 G1047S | 1047 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL2A1 G1053A | 1053 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| SLC26A2 G259V | 259 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC26A2 L483P | 483 | Pathogenic / likely pathogenic (★★) | |
| SLC26A2 C653G | 653 | STAS | Pathogenic / likely pathogenic (★★) |
| SLC26A2 G663R | 663 | STAS | Pathogenic / likely pathogenic (★★) |
| COL2A1 A302V | 302 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| SLC26A2 H665P | 665 | STAS | Pathogenic / likely pathogenic (★★) |
| SLC26A2 G678V | 678 | STAS | Pathogenic / likely pathogenic (★★) |
| SLC26A2 A386G | 386 | Transmembrane | Pathogenic / likely pathogenic (★) |
| COL2A1 G507E | 507 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL2A1 G660E | 660 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL2A1 G765S | 765 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL2A1 G846E | 846 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL2A1 G912S | 912 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL2A1 G915E | 915 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL2A1 G945R | 945 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL2A1 G981S | 981 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL2A1 G999C | 999 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL2A1 G1014R | 1014 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL2A1 G1026D | 1026 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL2A1 G1038E | 1038 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL2A1 G1089R | 1089 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL2A1 G1107E | 1107 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| COL2A1 G1158R | 1158 | Triple-helical region | Pathogenic / likely pathogenic (★) |
| SLC26A2 I426N | 426 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC26A2 I426T | 426 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC26A2 W505R | 505 | Pathogenic / likely pathogenic (★) | |
| SLC26A2 A715T | 715 | STAS | Pathogenic / likely pathogenic (★) |
| SLC26A2 M1I | 1 | Pathogenic / likely pathogenic (★) | |
| COL2A1 G546V | 546 | Triple-helical region | Pathogenic / likely pathogenic |
| COL2A1 G411E | 411 | Triple-helical region | Pathogenic / likely pathogenic |
| COL2A1 G447D | 447 | Triple-helical region | Pathogenic / likely pathogenic |
| COL2A1 G516D | 516 | Triple-helical region | Pathogenic / likely pathogenic |
| COL2A1 G636D | 636 | Triple-helical region | Pathogenic / likely pathogenic |
| COL2A1 G651V | 651 | Triple-helical region | Pathogenic / likely pathogenic |
| COL2A1 G705D | 705 | Triple-helical region | Pathogenic / likely pathogenic |
| COL2A1 G891R | 891 | Triple-helical region | Pathogenic / likely pathogenic |
| COL2A1 G969S | 969 | Triple-helical region | Pathogenic / likely pathogenic |
Which prediction tools work for Achondrogenesis type II
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 97 out of 100
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 94 out of 100
- VARITY: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 94 out of 100
- MetaLR: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 90 out of 100
- PolyPhen-2: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 89 out of 100
- phyloP: 82 out of 100
- phastCons: 69 out of 100
- SpliceAI: 59 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 46 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Spondyloepiphyseal dysplasia congenita also has ClinVar records linked to COL2A1 variants; they fall mostly in different places as the Achondrogenesis type II variants (38 pathogenic / likely pathogenic).
- Stickler syndrome also has ClinVar records linked to COL2A1 variants; they fall mostly in different places as the Achondrogenesis type II variants (26 pathogenic / likely pathogenic).
- Spondyloepimetaphyseal dysplasia, Strudwick type also has ClinVar records linked to COL2A1 variants; they fall mostly in different places as the Achondrogenesis type II variants (18 pathogenic / likely pathogenic).
- Connective tissue disease also has ClinVar records linked to COL2A1 variants; they fall partly in the same places as the Achondrogenesis type II variants (15 pathogenic / likely pathogenic).
- Type 2 collagenopathy also has ClinVar records linked to COL2A1 variants; they fall mostly in different places as the Achondrogenesis type II variants (14 pathogenic / likely pathogenic).
- Diastrophic dysplasia also has ClinVar records linked to SLC26A2 variants; they fall partly in the same places as the Achondrogenesis type II variants (16 pathogenic / likely pathogenic).
- Multiple epiphyseal dysplasia also has ClinVar records linked to SLC26A2 variants; they fall partly in the same places as the Achondrogenesis type II variants (12 pathogenic / likely pathogenic).
- Atelosteogenesis also has ClinVar records linked to SLC26A2 variants; they fall partly in the same places as the Achondrogenesis type II variants (11 pathogenic / likely pathogenic).
Diseases related to Achondrogenesis type II
- Multiple epiphyseal dysplasia, also linked to COL2A1 and SLC26A2
- Connective tissue disease, also linked to COL2A1 and SLC26A2
- Stickler syndrome, also linked to COL2A1
- Spondyloepiphyseal dysplasia congenita, also linked to COL2A1
- Spondyloepimetaphyseal dysplasia, Strudwick type, also linked to COL2A1
- Atelosteogenesis, also linked to SLC26A2
- Diastrophic dysplasia, also linked to SLC26A2
- Type 2 collagenopathy, also linked to COL2A1
- Spondyloperipheral dysplasia, also linked to COL2A1
- Fetal anomalies with a likely genetic cause, also linked to COL2A1
- Spondyloepiphyseal dysplasia, Stanescu type, also linked to COL2A1
- Platyspondylic dysplasia, Torrance type, also linked to COL2A1
Frequently asked questions
Which genes have records linked to Achondrogenesis type II?
This view contains 2 analyzed proteins: COL2A1, SLC26A2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 48 pathogenic or likely pathogenic variants, 131 variants of uncertain significance and 30 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 239 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center